Resveratrol makes breast cancer cells more susceptible to a poly ADP-ribose polymerase inhibitor (PARPi), known as talazoparib, by simultaneously suppressing AKT signaling and autophagy flux. The gene discussed is AKT1; the disease is breast cancer.